CD4 T-cell immune stimulation of HER2 + breast cancer cells alters response to trastuzumab in vitro

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1475-2867

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: CD4 T-cell immune stimulation of HER2 + breast cancer cells alters response to trastuzumab in vitro ; volume:20 ; number:1 ; day:10 ; month:11 ; year:2020 ; pages:1-11 ; date:12.2020
Cancer cell international ; 20, Heft 1 (10.11.2020), 1-11, 12.2020

Creator: Song, Patrick N.
Mansur, Ameer
Dugger, Kari J.
Davis, Tessa R.
Howard, Grant
Yankeelov, Thomas E.
Sorace, Anna G.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12935-020-01625-w

URN: urn:nbn:de:101:1-2020122022351800852132

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Song, Patrick N.
Mansur, Ameer
Dugger, Kari J.
Davis, Tessa R.
Howard, Grant
Yankeelov, Thomas E.
Sorace, Anna G.
SpringerLink (Online service)

Other Objects (12)

The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2

CD4 T-cell help sustains distinct subpopulations in functional and dysfunctional CD8 T-cell responses.

m6A methyltransferase METTL3 programs CD4+ T-cell activation and effector T-cell differentiation in systemic lupus erythematosus

Hochschulschrift

CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma

Induction of a memory‐like CD4 + T‐cell phenotype by airway smooth muscle cells

Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation

CD160 isoforms and regulation of CD4 and CD8 T-cell responses

Identification of clinically relevant CD4+ T-cell epitopes from HCMV antigens

UCP-2 inhibitor enhanced the efficacy of trastuzumab against HER2 positive breast cancer cells

Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neu-positive breast cancer cells

MHC class II‐deficient mice allow functional human CD4 + T‐cell development

CTLA-4 antibody ipilimumab negatively affects CD4+ T-cell responses in vitro

The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2

CD4 T-cell help sustains distinct subpopulations in functional and dysfunctional CD8 T-cell responses.

m6A methyltransferase METTL3 programs CD4+ T-cell activation and effector T-cell differentiation in systemic lupus erythematosus

Hochschulschrift

CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma

Induction of a memory‐like CD4 + T‐cell phenotype by airway smooth muscle cells

Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation

CD160 isoforms and regulation of CD4 and CD8 T-cell responses

Identification of clinically relevant CD4+ T-cell epitopes from HCMV antigens

UCP-2 inhibitor enhanced the efficacy of trastuzumab against HER2 positive breast cancer cells

Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neu-positive breast cancer cells

MHC class II‐deficient mice allow functional human CD4 + T‐cell development

CTLA-4 antibody ipilimumab negatively affects CD4+ T-cell responses in vitro

The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2

CD4 T-cell help sustains distinct subpopulations in functional and dysfunctional CD8 T-cell responses.

m6A methyltransferase METTL3 programs CD4+ T-cell activation and effector T-cell differentiation in systemic lupus erythematosus

Hochschulschrift

CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma

Induction of a memory‐like CD4 + T‐cell phenotype by airway smooth muscle cells

Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation

CD160 isoforms and regulation of CD4 and CD8 T-cell responses

Identification of clinically relevant CD4+ T-cell epitopes from HCMV antigens

UCP-2 inhibitor enhanced the efficacy of trastuzumab against HER2 positive breast cancer cells

Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neu-positive breast cancer cells

MHC class II‐deficient mice allow functional human CD4 + T‐cell development

CTLA-4 antibody ipilimumab negatively affects CD4+ T-cell responses in vitro

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

CD4 T-cell immune stimulation of HER2 + breast cancer cells alters response to trastuzumab in vitro

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2

CD4 T-cell help sustains distinct subpopulations in functional and dysfunctional CD8 T-cell responses.

m6A methyltransferase METTL3 programs CD4+ T-cell activation and effector T-cell differentiation in systemic lupus erythematosus

CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma

Induction of a memory‐like CD4 + T‐cell phenotype by airway smooth muscle cells

Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation

CD160 isoforms and regulation of CD4 and CD8 T-cell responses

Identification of clinically relevant CD4+ T-cell epitopes from HCMV antigens

UCP-2 inhibitor enhanced the efficacy of trastuzumab against HER2 positive breast cancer cells

Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neu-positive breast cancer cells

MHC class II‐deficient mice allow functional human CD4 + T‐cell development

CTLA-4 antibody ipilimumab negatively affects CD4+ T-cell responses in vitro

The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2

CD4 T-cell help sustains distinct subpopulations in functional and dysfunctional CD8 T-cell responses.

m6A methyltransferase METTL3 programs CD4+ T-cell activation and effector T-cell differentiation in systemic lupus erythematosus

CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma

Induction of a memory‐like CD4 + T‐cell phenotype by airway smooth muscle cells

Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation

CD160 isoforms and regulation of CD4 and CD8 T-cell responses

Identification of clinically relevant CD4+ T-cell epitopes from HCMV antigens

UCP-2 inhibitor enhanced the efficacy of trastuzumab against HER2 positive breast cancer cells

Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neu-positive breast cancer cells

MHC class II‐deficient mice allow functional human CD4 + T‐cell development

CTLA-4 antibody ipilimumab negatively affects CD4+ T-cell responses in vitro

The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2

CD4 T-cell help sustains distinct subpopulations in functional and dysfunctional CD8 T-cell responses.

m6A methyltransferase METTL3 programs CD4+ T-cell activation and effector T-cell differentiation in systemic lupus erythematosus

CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma

Induction of a memory‐like CD4 + T‐cell phenotype by airway smooth muscle cells

Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation

CD160 isoforms and regulation of CD4 and CD8 T-cell responses

Identification of clinically relevant CD4+ T-cell epitopes from HCMV antigens

UCP-2 inhibitor enhanced the efficacy of trastuzumab against HER2 positive breast cancer cells

Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neu-positive breast cancer cells

MHC class II‐deficient mice allow functional human CD4 + T‐cell development

CTLA-4 antibody ipilimumab negatively affects CD4+ T-cell responses in vitro

Related objects

Reset password